Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
27.30
+0.32 (+1.20%)
Streaming Delayed Price
Updated: 3:20 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns
April 30, 2024
Safe haven stocks offer stability even during market fall in communication, financials, healthcare, energy and consumer staples.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
April 30, 2024
Via
Benzinga
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings
April 30, 2024
Pfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has declined 34.61% YoY and -10.94% YTD due to COVID-19 revenue decrease. Technical analysis shows bearish...
Via
Benzinga
Exposures
COVID-19
(PFE) - Analyzing Pfizer's Short Interest
April 30, 2024
Via
Benzinga
5 Top Stocks to Buy in May
April 30, 2024
Whether you're looking for a proven player, passive income, or a breakout growth story, there are plenty of stocks worth buying this spring.
Via
The Motley Fool
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pfizer's Options: A Look at What the Big Money is Thinking
April 26, 2024
Via
Benzinga
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
April 30, 2024
The sun could be peeking through the dark clouds for Pfizer.
Via
The Motley Fool
Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead
April 30, 2024
Wall Street's brightest, most successful billionaire money managers are ditching Nvidia in favor of two time-tested income stocks with yields of 6.6%!
Via
The Motley Fool
mRNA Is Promising A Breakthrough In Fighting Cancer
April 29, 2024
When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as it...
Via
Benzinga
Exposures
COVID-19
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
April 29, 2024
These stocks aren't bargains.
Via
The Motley Fool
3 Dividend Stocks to Buy on the Dip: April 2024
April 29, 2024
With the market presenting many vagaries, investors may take some solace in these dividend stocks to buy on the dip.
Via
InvestorPlace
Is Viking Therapeutics Incredibly Undervalued?
April 28, 2024
The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.
Via
The Motley Fool
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
April 28, 2024
Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.
Via
The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
April 27, 2024
You'll get dividends and more with these great stocks.
Via
The Motley Fool
7 Dividend Stocks to Buy Now for Steady Returns in Any Market
April 27, 2024
Passive investors pay attention! Invest in the best of the best with these seven dividend stocks for steady returns.
Via
InvestorPlace
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
April 26, 2024
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
April 26, 2024
FDA approves Pfizer's Beqvez for adults with hemophilia B, offering a one-time treatment to produce FIX. Experience reduced bleeding frequency. Explore Pfizer's warranty program.
Via
Benzinga
Exposures
Product Safety
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks
April 26, 2024
Put your money to work by investing in these three high-quality dividend stocks.
Via
The Motley Fool
Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy
April 26, 2024
Pfizer won FDA approval for a new hemophilia B gene therapy, a rival to Hemgenix from CSL and Uniqure.
Via
Investor's Business Daily
Exposures
Product Safety
What's Going On With Pfizer Stock On Thursday?
April 25, 2024
GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying high-stakes legal battles in the U.S.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
April 25, 2024
The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate.
Via
Investor's Business Daily
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
April 25, 2024
Via
Benzinga
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
April 24, 2024
Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco.
Via
InvestorPlace
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly.
Via
InvestorPlace
3 Defensive Stocks To Protect Your Portfolio In 2024
April 23, 2024
Alcohol, tobacco, and drugs as bulwarks against market shocks, and these three stocks are now trading under low ballparks.
Via
Talk Markets
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
April 23, 2024
Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
April 23, 2024
These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.
Via
InvestorPlace
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
These two pharma stocks have followed distinct paths of late. Which is the better investment?
Via
The Motley Fool
1 No-Brainer Vanguard Fund to Buy Right Now
April 23, 2024
This Vanguard growth fund is home to some of the world's most innovative companies.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.